Stocks · Korea 256840 KOSDAQ

BNC Korea

3,285원 +2.98% Market cap 2,247억 2026-10-07 close
Data as of 2026-10-07 · Linked from 7 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER78.21x
PBR0.96x
EPS42 KRW
BPS3,417 KRW
ROE-1.87%
DPS70 KRW

Returns and 52-week range

1W-0.30%
1M+25.38%
3M+25.62%
6M-15.88%
1Y-36.58%
YTD-27.96%
52W high6,180원
52W low2,050원
From 52W high-46.84%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
2022423억-101억-445억-23.9%
2023810억60억261억7.5%
2024892억107억133억12.0%
2025959억16억20억1.7%
Quarterly
2024 4Q258억17억86억6.7%
2025 1Q254억38억51억14.9%
2025 2Q246억16억3억6.5%
2025 3Q223억-14억-4억-6.3%
2025 4Q236억-24억-30억-10.0%
2026 1Q207억-15억-13억-7.1%

Company

CEO최완규
Founded2016-10-14
Fiscal year end12
Address: 대구광역시 달서구 성서공단로11길 62 대구테크노파크 벤처공장 1호관 405호(사무실),502호, 503호, 206호,

Peers in the same sector

CompanyMarket capP/EP/B1M
대화제약2,258억129.042.93+14.43%
바이오니아2,245억—1.07-15.14%
휴온스2,323억5.310.60-7.45%
제테마2,233억—3.29-6.70%
콜마비앤에이치2,351억—0.65-7.16%
듀켐바이오2,222억34.064.49+26.01%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Recent news

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.